Bintrafusp alfa plus paclitaxel for advanced gastric cancer as a second-line treatment: An open label, single-arm, phase Ib/II study.

被引：0
|
作者：
Lee, Choong-kun
Jung, Minkyu
Park, Sejung
Kwon, Woo Sun
Kim, Kyoo Hyun
Hong, Moonki
Kim, Hyunwook
Kim, Hyo Song
Chung, Hyun Cheol Cheol
Rha, Sun Young
机构：
[1] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol,Yonsei Canc Ctr, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Songdang Inst Canc Res, Seoul, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
374
引用
收藏
页码：374 / 374
页数：1
相关论文
共 50 条
  • [1] A phase Ib single-arm study of bintrafusp alfa for the treatment of pretreated, locally advanced/unresectable or metastatic urothelial cancer.
    Grivas, Petros
    Morales-Barrera, Rafael
    Sridhar, Srikala S.
    Loriot, Yohann
    Van der Heijden, Michiel Simon
    Galsky, Matt D.
    Baxter, Dawn
    Khaled, Ahmed Hussein
    Hug, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [2] Anlotinib combined with mXELIRI as second-line treatment in advanced colorectal cancer pretreated with bevacizumab plus standard chemotherapy: A single-arm, phase IB/II study
    Qu, Xin
    Chen, Xian
    Li, Yong
    Liu, Li-rong
    Qu, Yan-chun
    Hou, Fang-fang
    Li, Wen-zhu
    Liu, Yi-hong
    Zhu, Yan-juan
    Zhang, Haibo
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [3] A phase Ib/II study of fruquintinib in combination with paclitaxel as the second-line therapy for advanced gastric cancer
    Zhang, Yang
    Wang, Zi-Xian
    Shen, Lin
    Li, Jin
    Huang, Jing
    Su, Wei-Guo
    Zhang, Dong-Sheng
    Xu, Rui-Hua
    CANCER COMMUNICATIONS, 2023, 43 (01) : 150 - 153
  • [4] Toripalimab combined with nab-paclitaxel/docetaxel as second-line treatment in patients with advanced gastric cancer: Preliminary results from a single-arm, open-label phase II trial
    Zhang, T.
    Yu, D.
    Wang, J.
    Liu, J.
    Ma, H.
    Lin, Z.
    Jin, M.
    Zhang, J.
    Zhao, L.
    Liu, H.
    Hu, J.
    Zhang, Q.
    ANNALS OF ONCOLOGY, 2021, 32 : S1057 - S1058
  • [5] Gemcitabine plus nab-paclitaxel for second-line therapy of pancreatic cancer: A phase II, single-arm, multicenter study
    Huh, Gunn
    Choi, Jin Ho
    Lee, Sang Hyub
    Chun, Jung Won
    Cho, In Rae
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    Lee, Hee Seung
    Bang, Seungmin
    ANNALS OF ONCOLOGY, 2021, 32 : S287 - S287
  • [6] Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial
    Huh, Gunn
    Lee, Hee Seung
    Choi, Jin Ho
    Lee, Sang Hyub
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    Bang, Seungmin
    Lee, Eaum Seok
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [7] Camrelizumab in combination with apatinib as second-line treatment for advanced esophageal squamous cell carcinoma: A single-arm, open-label, phase II study
    Wang Feng
    Wang Junsheng
    Wu Tao
    Hong Yonggui
    Meng Xiangrui
    Ren Zhonghai
    Guo Yanzhen
    Yang Xiuli
    Shi Pei
    Yang Jiamei
    Fan Qingxia
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [8] Irinotecan plus raltitrexed as second-line treatment in locally advanced or metastatic colorectal cancer patients: a prospective open-label, single-arm, multi-center, phase II study
    Cheng, Yu
    Teng, Zan
    Zhang, Yanqiao
    Jin, Bo
    Zheng, Zhendong
    Man, Li
    Wang, Zhenghua
    Teng, Yuee
    Yu, Ping
    Shi, Jing
    Luo, Ying
    Wang, Ying
    Zhang, Jingdong
    Zhang, Huijuan
    Liu, Jiwei
    Chen, Hao
    Xiao, Jiawen
    Zhao, Lei
    Zhang, Lingyun
    Jiang, Yu
    Chen, Ying
    Zhang, Jian
    Wang, Chang
    Liu, Sa
    Qu, Jinglei
    Qu, Xiujuan
    Liu, Yunpeng
    BMC CANCER, 2024, 24 (01)
  • [9] Gemcitabine plus Nab-paclitaxel as a second-line treatment for patients with advanced pancreatic cancer after FOLFIRINOX failure: a multicenter, single-arm, open-label, phase 2 trial
    Choi, Jin Ho
    Lee, Hee Seung
    Huh, Gunn
    Lee, Sang Hyub
    Paik, Woo Hyun
    Ryu, Ji Kon
    Kim, Yong-Tae
    Bang, Seungmin
    Lee, Eaum Seok
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 122 - 122
  • [10] Efficacy and safety of second-line therapy with apatinib combined with chemotherapy as second-line therapy in advanced gastric cancer: a single-arm, open-label, prospective, multicenter study
    Zhang, Yan
    Xu, Junying
    Wang, Qiong
    Ling, Guohong
    Mao, Yong
    Cai, Maohuai
    Yang, Yang
    Mei, Jingfeng
    Han, Zhengxiang
    Feng, Jifeng
    Wu, Yuan
    Shi, Lin
    Wen, Shaodi
    Shen, Bo
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (11)
12345